Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Shares Outstanding (2023 - 2025)

Beta Bionics' Shares Outstanding history spans 3 years, with the latest figure at $44.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 565.3% year-over-year to $44.4 million; the TTM value through Dec 2025 reached $44.4 million, up 565.3%, while the annual FY2025 figure was $44.4 million, 565.3% up from the prior year.
  • Shares Outstanding for Q4 2025 was $44.4 million at Beta Bionics, up from $44.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $44.4 million in Q4 2025 and bottomed at $6.0 million in Q4 2023.
  • The 3-year median for Shares Outstanding is $6.7 million (2024), against an average of $23.0 million.
  • The largest annual shift saw Shares Outstanding rose 10.74% in 2024 before it soared 619.91% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $6.0 million in 2023, then grew by 10.74% to $6.7 million in 2024, then soared by 565.3% to $44.4 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Shares Outstanding are $44.4 million (Q4 2025), $44.0 million (Q3 2025), and $43.5 million (Q2 2025).